Categories
News

Smart Inhalers Market Report Examines Analysis by Latest Trends, Growth Factors, Key Players and 2026

The smart inhalers market is projected to gain market revenue of US$ 4,563.1 million by 2026, growing at a CAGR of 15.72% during the forecast period 2020-2026. Owing to the rising adoption of Smart Inhaler services due to the rapid increase in the aging population along with respiratory disorders associated with them. Moreover, increasing incidence of respiratory diseases, the rise in air pollution, and growth in healthcare burden owing to higher cases of asthma and COPD. Better treatment options, ease of use, and technological advancements coupled with the increase in adherence rate of patients to smart inhalers are other major factors that drive this market. Healthcare is the fundamental necessity of every individual however; the soaring cost of healthcare makes it unaffordable for several people. Moreover, the lack of reimbursement and limited availability of smart inhalers in developing regions are expected to restrain the global smart inhalers’ market growth. These inhalers Inhalers and nebulizers are bifurcated into metered-dose inhalers, dry powder inhalers and nebulizers.

Request for Sample of the report browse through – https://univdatos.com/request_form/form/232

Based on product type, the report bifurcates the global smart inhalers market into Inhaler (Metered Dose Inhalers, Dry Powder Inhalers) and nebulizers. The market of metered-dose inhalers is expected to grow tremendously at a CAGR of 15.1% during the forecast period 2020-2026, due to the high adoption of these devices. Based on indication, the global smart inhaler market is segmented into Chronic Obstructive Pulmonary Disorder (COPD) and asthma. The COPD occupied the largest share and is expected to maintain its dominance throughout the forecast period 2020-2026 owing to COPD is expected to be the third leading cause of death globally by 2030. The segment generated revenue of US$ 835.5 million in 2018. Chronic Obstructive Pulmonary Disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. According to the National Institutes of Health Trusted Source (NIH), around 24 million in America alone have COPD. Amongst the prevalence of COPD and asthma, COPD is expected to be the third leading cause of death globally by 2030. COPD is a life-threatening disease that accounts for about 5% of the yearly global deaths. Thus, the increasing prevalence of COPD will provide growth to the smart inhaler market over the forecast period.

To analyze the ongoing and projected development under the smart inhaler technology browse through –  https://univdatos.com/report/smart-inhaler-market-current-analysis-and-forecast-2019-2026

Based on Distribution Channel, the report bifurcates the market into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. In 2018, Hospital Pharmacies segment generated revenue of US$ 1,015.03 million, however, Online Pharmacies segment is expected to witness highest CAGR growth of 23.5% during the analyzed period. For in-depth understanding of the market adoption of Smart Inhaler, the industry is analyzed based on geographies and countries comprising North America (the U.S, Canada and rest of North America), Europe (Germany, Spain, the U.K., France, Italy and Rest of Europe), Asia-Pacific (Japan, India, China, Australia and Rest of Asia-Pacific), and Rest of the World. Further, the rise in geriatric population and age-related respiratory disorders such as COPD in North America as well as Asia-Pacific are estimated to fuel the Smart Inhaler market in both the regions in the upcoming years.

Browse – Nanotechnology in Drug Delivery Market: Current Analysis and Forecast (2020-2027)

Boehringer Ingelheim, Cohero Health, Inc., Omron Corporation, Novartis, AstraZeneca, Teva Pharmaceuticals Industries Ltd., Vectura Group, GlaxoSmithKline, Adherium Limited, 3M are some of the prominent players operating in the Global Smart Inhaler market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Browse – mHealth Apps Market

Global Smart Inhalers Market Segmentation

Market Insights, by Product Type

  • Inhalers
    • Metered Dose Inhalers
    • Dry Powder Inhalers
  • Nebulizers

Market Insights, by Indication

  • COPD
  • Asthma

Market Insights, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Insights, by End-User

  • Hospitals & Clinics
  • Respiratory Care Centre
  • Others

Market Insights, by Region

  • North America Smart Inhaler market
    • United States
    • Canada
    • Rest of North America
  • Europe Smart Inhaler market
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific Smart Inhaler market
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World Smart Inhaler market

Top Company Profiles

  • Boehringer Ingelheim group
  • Cohero Health, Inc.
  • Omron Corporation
  • Novartis AG
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Limited
  • Vectura Group plc
  • GlaxoSmithKline
  • Adherium Limited
  • 3M Drug Delivery Systems

UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Smart Inhalers Market can be customized to the country level or any other market segment.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definition
1.2 Objective of the Study
1.3 Limitation
1.4 Stakeholders
1.5 Currency used in the Report
1.6 Scope of the Global Smart Inhaler Market Study
2 RESEARCH METHODOLOGY
2.1 Research Methodology adopted for Global Smart Inhaler Market study
2.1.1 Main objective of the Global Smart Inhaler Market Study
3 REGULATORY FRAMEWORK
3.1 General Overview
3.1.1 US Regulations for Wearable Medical Devices
3.1.1.1 Legal Framework for Medical Device Regulation
3.1.1.2 FDA Flexibility on Low-Risk Mobile Applications
3.1.1.3 Legal Framework for Health Data Privacy
3.1.2 Japan Regulations for Wearable Medical Devices
3.1.2.1 List of software Under Regulation
3.1.2.2 Legal Framework for Health Data Privacy
3.1.3 European Regulations for Wearable Medical Devices
3.1.3.1 EU Strict Rules on Medical Device Software
3.1.3.2 Legal Framework for Health Data Privacy
4 INDUSTRY PERFORMANCE
5 EXECUTIVE SUMMARY
6 MARKET OVERVIEW
6.1 Introduction
6.2 Market Dynamics
6.2.1 Market Drivers
6.2.1.1 Accelerating Geriatric Population
6.2.1.2 Increasing Prevalence of Respiratory Disorders
6.2.1.3 Rising Air Pollution
6.2.1.3.1 Facts About Air Pollution:
6.2.1.4 Rising Healthcare Expenditure and Health-Conscious Personals
6.2.1.5 Growing Penetration of Smart Phones
6.2.2 Market Restraints
6.2.2.1 Overall High Cost of Inhalers
6.2.2.2 Misusing Data and Data Privacy
6.2.2.3 Lack of Awareness
6.2.3 Market Trends
6.2.3.1 Increasing demand for connected devices
6.2.3.2 Significant Growth in IoMT Market
7 EMERGENCE OF SMART INHALER MARKET
7.1 General Overview
7.2 Connected Device as a Solution
7.2.1 Potential Benefits of Smart Inhaler
7.2.1.1 Patients:
7.2.1.2 Healthcare provider:
7.2.1.3 Pharmaceutical company:
7.3 Partnerships Between Several Pharma and Technology/ Device Companies
8 PATIENT CONCERNS REGARDING SMART INHALERS AND CASE STUDIES
8.1 The Survey
8.2 Case Studies
8.2.1 Lyndsey Affected with Poor Asthma Symptoms
8.2.2 Jaswinder Seeking Solution for Her Daughter’s Asthma
8.2.3 Adrian Using Connected Peak Flow for Monitoring Asthma
8.2.4 Matthew Worrying About the Worsening of His Asthma
9 KEY MARKET INDICATORS
9.1 Demand Side Analysis
9.2 Supply Side Analysis
9.2.1 Product Launch
9.2.2 Partnerships
9.2.3 Business Expansion & Investments
9.2.4 Merger and Acquisitions
9.3 Value Chain Analysis of Smart Inhaler Market
10 MARKET INSIGHTS BY PRODUCT
10.1 General Overview
10.1.1 Inhalers
10.1.1.1 Dry Powder Inhaler (DPI)
10.1.1.2 Metered Dose Inhaler (MDI)
10.1.2 Nebulizers
11 MARKET INSIGHTS BY INDICATION
11.1 General Overview
11.1.1 Chronic Obstructive Pulmonary Disease (COPD)
11.1.2 Asthma
12 MARKET INSIGHTS BY DISTRIBUTION CHANNEL
12.1 General Overview
12.1.1 Hospital Pharmacies
12.1.2 Retail Pharmacies
12.1.3 Online Channel
13 MARKET INSIGHTS, BY END-USER
13.1 General Overview
13.1.1 Hospitals & Clinics
13.1.2 Respiratory Care Centre
13.1.3 Others
14 MARKET INSIGHTS BY REGION/COUNTRY
14.1 General Overview
14.2 North America Smart Inhaler Market
14.2.1 North America Smart Inhalers Market, by Product
14.2.2 North America Smart Inhalers Market, by Indication
14.2.3 North America Smart Inhalers Market, by Distribution Channel
14.2.4 North America Smart Inhalers Market, by End-Users
14.2.5 North America Smart Inhalers Market, by Country
14.2.5.1 United States Smart Inhaler Market
14.2.5.1.1 Key Findings on Healthcare Spending in the US, 2017
14.2.5.1.2 US Health Spending by Type of Service or Product, 2017
14.2.5.1.3 Health Spending by Major Sources of Funds
14.2.5.1.4 US Smart Inhalers Market, by Product
14.2.5.1.5 US Smart Inhalers Market, by Indication
14.2.5.1.6 US Smart Inhalers Market, by Distribution Channel
14.2.5.1.7 US Smart Inhalers Market, by End-Users
14.2.5.2 Canada Smart Inhaler Market
14.2.5.2.1 Key Facts on Total Hospital Cost, by Health Conditions Canada, 2016
14.2.5.2.2 Key Findings on Canada Healthcare Spending, 2018
14.2.5.2.3 Key Findings on Hospital sector Spending in Canada, 2018
14.2.5.2.4 Canada Smart Inhalers Market, by Product
14.2.5.2.5 Canada Smart Inhalers Market, by Indication
14.2.5.2.6 Canada Smart Inhalers Market, by Distribution Channel
14.2.5.2.7 Canada Smart Inhalers Market, by End-Users
14.2.5.3 Rest of the NA Smart Inhaler Market
14.2.5.3.1 Key Findings on Healthcare Spending in Mexico, 2016
14.2.5.3.2 Rest of NA Smart Inhalers Market, by Product
14.2.5.3.3 Rest of NA Smart Inhalers Market, by Indication
14.2.5.3.4 Rest of NA Smart Inhalers Market, by Distribution Channel
14.2.5.3.5 Rest of NA Smart Inhalers Market, by End-Users
14.3 Europe Smart Inhaler Market
14.3.1 Europe Smart Inhalers Market, by Product
14.3.2 Europe Smart Inhalers Market, by Indication
14.3.3 Europe Smart Inhalers Market, by Distribution Channel
14.3.4 Europe Smart Inhalers Market, by End-Users
14.3.5 Europe Smart Inhalers Market, by Country
14.3.5.1 Germany Smart Inhaler Market
14.3.5.1.1 Facts on COPD and Asthma in Germany
14.3.5.1.2 Germany Smart Inhalers Market, by Product
14.3.5.1.3 Germany Smart Inhalers Market, by Indication
14.3.5.1.4 Germany Smart Inhalers Market, by Distribution Channel
14.3.5.1.5 Germany Smart Inhalers Market, by End-Users
14.3.5.2 United Kingdom Smart Inhaler Market
14.3.5.2.1 United Kingdom Smart Inhalers Market, by Product
14.3.5.2.2 United Kingdom Smart Inhalers Market, by Indication
14.3.5.2.3 United Kingdom Smart Inhalers Market, by Distribution Channel
14.3.5.2.4 United Kingdom Smart Inhalers Market, by End-Users
14.3.5.3 Spain Smart Inhaler Market
14.3.5.3.1 Spain Smart Inhalers Market, by Product
14.3.5.3.2 Spain Smart Inhalers Market, by Indication
14.3.5.3.3 Spain Smart Inhalers Market, by Distribution Channel
14.3.5.3.4 Spain Smart Inhalers Market, by End-Users
14.3.5.4 France Smart Inhaler Market
14.3.5.4.1 France Smart Inhalers Market, by Product
14.3.5.4.2 France Smart Inhalers Market, by Indication
14.3.5.4.3 France Smart Inhalers Market, by Distribution Channel
14.3.5.4.4 France Smart Inhalers Market, by End-Users
14.3.5.5 Italy Smart Inhaler Market
14.3.5.5.1 Italy Smart Inhalers Market, by Product
14.3.5.5.2 Italy Smart Inhalers Market, by Indication
14.3.5.5.3 Italy Smart Inhalers Market, by Distribution Channel
14.3.5.5.4 Italy Smart Inhalers Market, by End-Users
14.3.5.6 Rest of Europe Smart Inhaler Market
14.3.5.6.1 Rest of Europe Smart Inhalers Market, by Product
14.3.5.6.2 Rest of Europe Smart Inhalers Market, by Indication
14.3.5.6.3 Rest of Europe Smart Inhalers Market, by Distribution Channel
14.3.5.6.4 Rest of Europe Smart Inhalers Market, by End-Users
14.4 Asia-Pacific Smart Inhaler Market
14.4.1 Asia-Pacific Smart Inhalers Market, by Product
14.4.2 Asia-Pacific Smart Inhalers Market, by Indication
14.4.3 Asia-Pacific Smart Inhalers Market, by Distribution Channel
14.4.4 Asia-Pacific Smart Inhalers Market, by End-Users
14.4.5 Asia-Pacific Smart Inhalers Market, by Country
14.4.5.1 China Smart Inhaler Market
14.4.5.1.1 China Smart Inhalers Market, by Product
14.4.5.1.2 China Smart Inhalers Market, by Indication
14.4.5.1.3 China Smart Inhalers Market, by Distribution Channel
14.4.5.1.4 China Smart Inhalers Market, by End-Users
14.4.5.2 India Smart Inhaler Market
14.4.5.2.1 India Smart Inhalers Market, by Product
14.4.5.2.2 India Smart Inhalers Market, by Indication
14.4.5.2.3 India Smart Inhalers Market, by Distribution Channel
14.4.5.2.4 India Smart Inhalers Market, by End-Users
14.4.5.3 Japan Smart Inhaler Market
14.4.5.3.1 Changing Demographic Structure of Japan
14.4.5.3.2 Japan Smart Inhalers Market, by Product
14.4.5.3.3 Japan Smart Inhalers Market, by Indication
14.4.5.3.4 Japan Smart Inhalers Market, by Distribution Channel
14.4.5.3.5 Japan Smart Inhalers Market, by End-Users
14.4.5.4 Australia Smart Inhaler Market (2018-2025)
14.4.5.4.1 Australia Smart Inhalers Market, by Product
14.4.5.4.2 Australia Smart Inhalers Market, by Indication
14.4.5.4.3 Australia Smart Inhalers Market, by Distribution Channel
14.4.5.4.4 Australia Smart Inhalers Market, by End-Users
14.4.5.5 South Korea Smart Inhaler Market
14.4.5.5.1 South Korea Smart Inhalers Market, by Product
14.4.5.5.2 South Korea Smart Inhalers Market, by Indication
14.4.5.5.3 South Korea Smart Inhalers Market, by Distribution Channel
14.4.5.5.4 South Korea Smart Inhalers Market, by End-Users
14.4.5.6 Rest of Asia-Pacific Smart Inhaler Market (2018-2025)
14.4.5.6.1 Rest of APAC Smart Inhalers Market, by Product
14.4.5.6.2 Rest of APAC Smart Inhalers Market, by Indication
14.4.5.6.3 Rest of APAC Smart Inhalers Market, by Distribution Channel
14.4.5.6.4 Rest of APAC Smart Inhalers Market, by End-Users
14.5 Rest of World Smart Inhaler Market (2018-2025)
14.5.1 Rest of World Smart Inhalers Market, by Product
14.5.2 Rest of World Smart Inhalers Market, by Indication
14.5.3 Rest of World Smart Inhalers Market, by Distribution Channel
14.5.4 Rest of World Smart Inhalers Market, by End-Users
15 COMPETITIVE SCENARIO
15.1 Porter’s Five forces analysis
15.1.1 Bargaining Power of Buyers
15.1.2 Bargaining power of Supplier
15.1.3 Threat of new entrants
15.1.4 Availability of Substitute
15.1.5 Industry Rivalry
15.3 Market Share Analysis, by Company 2019
16 TOP COMPANY PROFILES
16.1 Boehringer Ingelheim
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Key Product/Services Offerings
16.1.4 Growth Strategy
16.1.5 SWOT Analysis
16.1.6 Key Financials (2014-2018)
16.1.7 Revenue Split
16.1.8 Recent Developments
16.1.8.1 Product Launches
16.1.8.2 Business Expansion and Investments
16.2 Cohero Health, Inc.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Key Product/Services Offerings
16.2.4 Growth Strategy
16.2.5 SWOT Analysis
16.2.6 Recent Developments
16.2.6.1 Product Launches
16.2.6.2 Investment
16.3 Omron Corporation
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Key Product/Services Offerings
16.3.4 Growth Strategy
16.3.5 SWOT Analysis
16.3.6 Key Financials (2014-2018)
16.3.7 Revenue Split
16.4 Novartis
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Key Product/Services Offerings
16.4.4 Growth Strategy
16.4.5 SWOT Analysis
16.4.6 Key Financials (2014-2018)
16.4.7 Revenue Split
16.5 AstraZeneca
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Key Product/Services Offerings
16.5.4 Growth Strategy
16.5.5 SWOT Analysis
16.5.6 Key Financials
16.5.7 Revenue Split
16.5.8 Recent Developments
16.5.8.1 Product Launches
16.5.8.2 Business Expansion
16.6 Teva Pharmaceuticals Industries Ltd.
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Key Product/Services Offerings
16.6.4 Growth Strategy
16.6.5 SWOT Analysis
16.6.6 Key Financials (2014-2018)
16.6.7 Revenue Split
16.6.8 Recent Developments
16.6.8.1 Product Launch
16.6.8.2 Business Expansion
16.7 Vectura Group
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Key Product/Services Offerings
16.7.4 Growth Strategy
16.7.5 SWOT Analysis
16.7.6 Key Financials
16.7.7 Revenue Split
16.7.8 Recent Developments
16.7.8.1 Product Launches
16.7.8.2 Partnership
16.8 GlaxoSmithKline
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Key Product/Services Offerings
16.8.4 Growth Strategy
16.8.5 SWOT Analysis
16.8.6 Key Financials
16.8.7 Revenue Split
16.8.8 Recent Developments
16.8.8.1 Product Launches
16.8.8.2 Merger and Acquisitions
16.9 Adherium Limited
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Key Product/Services Offerings
16.9.4 Growth Strategy
16.9.5 SWOT Analysis
16.9.6 Key Financials (2014-2018)
16.9.6.1 Revenue Split
16.9.7 Recent Developments
16.9.7.1 Product Launches
16.9.7.2 Partnership
16.1 3M
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Key Product/Services Offerings
16.10.4 SWOT Analysis
16.10.5 Key Financials
16.10.6 Revenue Split
16.10.7 Recent Developments
16.10.7.1 Product Launches

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911

https://neighborwebsj.com/